- Home
- Results news
- HealthCare Global Enterprises
- Q2 FY27 results
HealthCare Global Enterprises Q2 FY27 results: net profit down 55.2% to ₹9.25 crore, revenue up 13.1%
HealthCare Global Enterprises Limited reported consolidated revenue of ₹731.80 crore in Q2 FY27, up 13.1% year on year, while EBITDA rose 8.2% to ₹133.39 crore. Net profit fell 55.2% to ₹9.25 crore and basic EPS declined to ₹0.32 from ₹1.16, with an exceptional charge of ₹11.59 crore and higher employee costs contributing to the pressure on profit.
Key points
- Consolidated revenue was ₹731.80 crore in Q2 FY27, up 13.1% from ₹646.85 crore in Q2 FY26 and 5.3% from ₹695.10 crore in Q1 FY27.
- EBITDA was ₹133.39 crore, up 8.2% year on year and 9.1% sequentially; the margin was 18.2%, compared with 19.1% in Q2 FY26 and 17.6% in Q1 FY27.
- Net profit was ₹9.25 crore, down 55.2% from ₹20.66 crore a year earlier and 43.8% from ₹16.46 crore in Q1 FY27; basic EPS was ₹0.32.
- Employee cost rose 21.6% year on year to ₹114.48 crore, while other expenses increased 14.9% to ₹289.74 crore and finance costs fell 11.9% to ₹38.42 crore.
- In H1 FY27, revenue rose 13.2% to ₹1,426.90 crore and PBT increased 35.3% to ₹41.59 crore, but net profit fell 3.5% to ₹25.71 crore.
How did HealthCare Global Enterprises perform in Q2 FY27?
HealthCare Global Enterprises reported consolidated revenue of ₹731.80 crore for Q2 FY27, up 13.1% from ₹646.85 crore in Q2 FY26 and 5.3% from ₹695.10 crore in Q1 FY27. EBITDA rose 8.2% year on year to ₹133.39 crore and 9.1% sequentially from ₹122.26 crore. The EBITDA margin was 18.2%, down 0.9 percentage points year on year but up 0.6 percentage points from the previous quarter.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 731.80 | 695.10 | 646.85 | +13.1% | +5.3% |
| Other income | 1.91 | 12.13 | 2.62 | −27.1% | −84.3% |
| Total expenses | 704.63 | 683.13 | 629.96 | +11.9% | +3.1% |
| EBITDA | 133.39 | 122.26 | 123.31 | +8.2% | +9.1% |
| EBITDA margin | 18.2% | 17.6% | 19.1% | −0.9 pp | +0.6 pp |
| Profit before tax | 17.49 | 24.10 | 19.51 | −10.4% | −27.4% |
| Tax | 9.24 | 8.57 | −0.84 | +7.8% | |
| Net profit | 9.25 | 16.46 | 20.66 | −55.2% | −43.8% |
| EPS (₹) | 0.32 | 0.92 | 1.16 | −72.4% | −65.2% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in HealthCare Global Enterprises' costs and profit?
Total expenses increased 11.9% year on year to ₹704.63 crore, against revenue growth of 13.1%, while the EBITDA margin fell 0.9 percentage points to 18.2%. Employee cost rose 21.6% to ₹114.48 crore, other expenses increased 14.9% to ₹289.74 crore and depreciation rose 8.0% to ₹67.80 crore. Finance costs fell 11.9% to ₹38.42 crore, while other income declined 27.1% to ₹1.91 crore.
Profit before tax fell 10.4% year on year to ₹17.49 crore. The company recorded an exceptional charge of ₹11.59 crore, compared with no exceptional item in Q2 FY26, and tax moved from a credit of ₹0.84 crore to a tax expense of ₹9.24 crore. Against Q1 FY27, other income fell 84.3% to ₹1.91 crore, employee cost rose 9.5% to ₹114.48 crore, and depreciation fell 3.7% to ₹67.80 crore.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 0 | 0 | |
| Employee cost | 114.48 | 94.18 | +20.30 | +21.6% |
| Finance costs | 38.42 | 43.62 | −5.20 | −11.9% |
| Depreciation | 67.80 | 62.80 | +5 | +8.0% |
| Other expenses | 289.74 | 252.21 | +37.53 | +14.9% |
| Total expenses | 704.63 | 629.96 | +74.67 | +11.9% |
| Other income | 1.91 | 2.62 | −0.71 | −27.1% |
| Tax | 9.24 | −0.84 | +10.08 | |
| Exceptional items | −11.59 (charge) | none |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
For H1 FY27, consolidated revenue was ₹1,426.90 crore, up 13.2% from ₹1,260.01 crore in H1 FY26, while total income rose 13.5% to ₹1,440.94 crore. PBT increased 35.3% to ₹41.59 crore from ₹30.75 crore, indicating that profit before tax increased faster than revenue over the first half.
Despite the rise in PBT, consolidated net profit for H1 FY27 was ₹25.71 crore, down 3.5% from ₹26.64 crore in H1 FY26. Basic EPS declined 17.3% to ₹1.24 from ₹1.50. The first-half figures are consolidated and cover the six months ended September 2026.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 1,427 | 1,260 | +13.2% |
| Profit before tax | 41.59 | 30.75 | +35.3% |
| Net profit | 25.71 | 26.64 | −3.5% |
| EPS (₹) | 1.24 | 1.50 | −17.3% |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
At September 2026, total assets were ₹3,729.86 crore, down from ₹3,922.54 crore at March 2026, while total equity rose to ₹1,434.22 crore from ₹1,410.21 crore. Borrowings fell to ₹742.37 crore from ₹910.41 crore, and cash declined to ₹120.18 crore from ₹536.05 crore. Inventories were ₹63.64 crore, trade receivables ₹485.73 crore and trade payables ₹403.45 crore.
H1 FY27 operating cash flow was ₹139.29 crore, compared with ₹192.25 crore in H1 FY26. Investing cash flow was negative ₹269.69 crore, against negative ₹58.00 crore, while financing cash flow was negative ₹224.66 crore, against negative ₹80.65 crore. Capital expenditure was ₹130.49 crore, compared with ₹158.32 crore a year earlier.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 3,730 | 3,923 |
| Total equity | 1,434 | 1,410 |
| Borrowings | 742.37 | 910.41 |
| Cash and equivalents | 120.18 | 536.05 |
| Inventories | 63.64 | 59.82 |
| Trade receivables | 485.73 | 420.70 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | 139.29 | 192.25 |
| Cash from investing | −269.69 | −58 |
| Cash from financing | −224.66 | −80.65 |
| Capital expenditure | 130.49 | 158.32 |
Source: Company's results filing (XBRL).
How has HealthCare Global Enterprises done over the last 8 quarters?
Revenue has risen year on year in each of the last eight quarters. It reached ₹731.80 crore in Q2 FY27, the highest level in the reported series, after rising from ₹695.10 crore in Q1 FY27. The lowest quarterly revenue shown was ₹557.55 crore in Q3 FY25. The EBITDA margin reached 18.2% in Q2 FY27, above 17.6% in Q1 FY27 but below 19.2% in Q4 FY26 and 19.1% in Q2 FY26.
Net profit reached ₹20.66 crore in Q2 FY26 and fell to negative ₹7.90 crore in Q3 FY26, the lowest point shown. It then recovered to ₹4.04 crore in Q4 FY26, rose to ₹16.46 crore in Q1 FY27 and eased to ₹9.25 crore in Q2 FY27.
What else did the company announce?
The board approved the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026 on 5 November 2026. In a separate same-day filing, the Nomination and Remuneration Committee approved the grant of 70,000 employee stock options under HCG ESOS 2026. Each option is exercisable into one equity share of face value INR 10 at an exercise price of INR 495 per share. No dividend, fund raise or appointment was stated in the filings provided.
How did other Hospital companies do?
Sixteen other Hospital companies filed for the quarter, with a median revenue growth of 20.6%, compared with HealthCare Global Enterprises’ 13.1% revenue growth. Fourteen peers grew faster than the company, while two grew more slowly. Among the 14 peers for which profit was compared, 10 reported higher profit.
| HealthCare Global Enterprises revenue growth (YoY) | +13.1% |
|---|---|
| Median of 16 other Hospital companies | +20.6% |
| Companies with slower revenue growth than HealthCare Global Enterprises | 2 of 16 |
| Companies with faster revenue growth than HealthCare Global Enterprises | 14 of 16 |
| Companies whose net profit rose | 10 of 14 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was HealthCare Global Enterprises' revenue in Q2 FY27?
Revenue from operations was ₹731.80 crore, up 13.1% from ₹646.85 crore in Q2 FY26 (consolidated).
Did HealthCare Global Enterprises make a profit in Q2 FY27?
Yes. Net profit was ₹9.25 crore, against a net profit of ₹20.66 crore in Q2 FY26.
What was HealthCare Global Enterprises' EPS in Q2 FY27?
Basic earnings per share were ₹0.32, against ₹1.16 in Q2 FY26.
When did HealthCare Global Enterprises announce its Q2 FY27 results?
On 5 November 2026, in a filing to the BSE.
Sources
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation (BSE, 13 October 2026) · PDF
- Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2026. (BSE, 5 November 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.